Dr. Neal F Mathews, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2452 Kuser Rd, Suite D, Hamilton Square, NJ 08690 Phone: 609-586-5009 Fax: 609-586-9905 |
Anthony C. Soriero D.c.l.l.c Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 3679a Nottingham Way, Hamilton Square, NJ 08690 Phone: 609-586-9199 Fax: 609-586-5766 |
Anthony C Soriero D.c. P.a. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 3679 A Nottingham Way, Hamilton Square, NJ 58690 Phone: 609-586-9199 Fax: 609-586-5766 |
Joseph E Jenkins, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2614 Whitehorse Hamilton Square Rd, Hamilton Square, NJ 08690 Phone: 609-587-8900 Fax: 609-587-1189 |
Dr. Karl James Natriello, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 1940 Yardville Hamilton Squ Rd, Hamilton Square, NJ 08690 Phone: 609-586-4100 Fax: 609-586-3683 |
Dr. Anthony C. Soriero, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 3679a Nottingham Way, Hamilton Square, NJ 08690 Phone: 609-586-9199 Fax: 609-586-5766 |
Back Care Professionals, Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2452 Kuser Rd Ste D, Hamilton Square, NJ 08690 Phone: 609-586-5009 Fax: 609-586-9905 |
News Archive
A team of researchers from the National University of Singapore has recently discovered that the Bandicoot Berry (Leea indica), South African leaf (Vernonia amygdalina) and Simple leaf Chastetree (Vitex trifolia), which are favorite nectaring plants of butterflies, do more than attract butterflies.
Michelson Diagnostics, a medical device company focused on applications of multi-beam Optical Coherence Tomography technology, today announces data showing that use of its VivoSight OCT scanner significantly improves diagnosis of basal-cell carcinoma at an earlier stage and reduces diagnostic biopsies by 36%.
A 6-year-old child who accidentally swallowed liquid nicotine intended for her parents' electronic cigarettes required immediate emergency medical treatment that included intubation and an overnight stay in a pediatric intensive care unit.
Nile Therapeutics, Inc., a biopharmaceutical company focused on the development of novel therapeutics for cardiovascular disease, today announced that it has completed the dosing of the last patient in NIL-CDNP-CT005, an open-label, single-blind, placebo-controlled Phase II study of CD-NP in patients with acute decompensated heart failure, or ADHF. The study was designed to provide additional information on the safety and tolerability of CD-NP when infused for up to 72 hours in patients with ADHF and mild to moderate renal insufficiency.
Their goal is to make the process easier during the next enrollment season. Meanwhile, Enroll America held a meeting to rally its troops as the organization also looks ahead to the next sign-up period.
› Verified 8 days ago